Skip to main content
. 2014 Jul 16;5(15):6404–6413. doi: 10.18632/oncotarget.2223

Figure 1.

Figure 1

Distribution of recurrent and mutually exclusive point mutations (green color) in known cancer genes as well as of deletions (red color) in CDKN2A, PTEN, TP53 and RB1 across BPDCN cases.